Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status

Authors

L. K. Shea
K. Honjo
D. T. Redden
E. Tabengwa
Li
J. Li
M. Shakhmatov
N. Chiorazzi, Zucker School of Medicine at Hofstra/Northwell
R. S. Davis

Publication Date

2019

Journal Title

Blood Cancer J

Volume Number

9

Issue Number

6

Pages

47

Document Type

Article

Status

Faculty

Facility

School of Medicine

Primary Department

Molecular Medicine

Additional Departments

General Internal Medicine

PMID

31092813

DOI

10.1038/s41408-019-0207-7